Ipledge
A Report from the Front Lines of Dermatologic Practice
Bibliographic Data
| ID | 15745176 |
|---|---|
| Authors | Diane Thiboutot (0000-0002-7342-2357, corresponding author), Clay J Cockerell (0000-0001-7125-0283, Pennsylvania State University) |
| Year | 2006 |
| Volume | 8 |
| Issue | 8 |
| Pages | 524-528 |
| Publication date | 2006-08-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | The AMA Journal of Ethic (JOURNAL) |
| Journal identifiers | ISSN: 2376-6980 • E-ISSN: 2376-6980 |
| Publisher | American Medical Association (PUBLISHER • US) |
| DOI | 10.1001/virtualmentor.2006.8.8.pfor1-0608 |
| PMID | 23234692 |
| OpenAlex | W120777324 |
| Language | EN |
March 1, 2006, marked an historic turning point in the practice of dermatology in the United States. On this date, the iPLEDGE program—a mandatory program for managing the risk of birth defects linked to isotretinoin—replaced a voluntary predecessor initiative notable for its reliance upon a yellow sticker placed on prescriptions to indicate the patient was qualified to receive the medication
Family medicine · Isotretinoin · Medical prescription · Acne and Rosacea Treatments and Effects · Medicine · Nursing · Dermatology
| Highly cited | No |
|---|